Abstract
Objectives
Serum IgG4 may often increases in allergic diseases. Eosinophilic granulomatosis with polyangiitis (EGPA) has an allergic phase. For this reason, it was questionable whether IgG4-RD and EGPA may share some clinical and laboratory features. In this study, we investigated whether definite IgG4-RD might share those features with EGPA.
Methods
We retrospectively reviewed the medical records of 42 Korean immunosuppressive drug-naïve patients with definite IgG4-RD. The American College of Rheumatology 1990 criteria for classification (the 1990 ACR criteria) for Churg-Strauss syndrome (CSS, known as EGPA) were applied to patients who were previously diagnosed with definite IgG4-RD and had no antineutrophil cytoplasmic antibody (ANCA). Definite IgG4-RD was defined when 3 components of the comprehensive diagnostic criteria were met.
Results
The median age of 42 patients was 61.0 years and 69% of them were men. The median serum IgG4 level was 379.0 mg/dL and the median IgG4+/IgG+ cells ratio was 50.0%. The most common biopsy site was the salivary gland (14.3%). Antinuclear antibody was detected in 6 patients, and test results for ANCA were negative in all patients. Among 42 patients with definite IgG4-RD without ANCA, none of them met the 1990 ACR classification criteria for EGPA.
Conclusions
Definite IgG4-RD found to have no overlap with EGPA when the 1990 ACR criteria for CCS were applied to Korean patients.
Key Points • None of 42 Korean patients with definite IgG4-RD without ANCA met the 1990 ACR classification criteria for EGPA. • Definite IgG4-RD found to have no overlap with EGPA in Korean patients without ANCA. |
Similar content being viewed by others
References
Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366(6):539–551. https://doi.org/10.1056/NEJMra1104650
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22(1):21–30. https://doi.org/10.1007/s10165-011-0571-z
Yamamoto M, Takahashi H, Shinomura Y (2014) Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol 10(3):148–159. https://doi.org/10.1038/nrrheum.2013.183
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH, Second International Symposium on IgG4-Related Disease (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67(7):1688–1699. https://doi.org/10.1002/art.39132
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. https://doi.org/10.1002/art.37715
Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66(2):222–227. https://doi.org/10.1136/ard.2006.054593
Kallenberg CG (2014) Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 10(8):484–493. https://doi.org/10.1038/nrrheum.2014.104
Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L (2013) Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis 72(8):1273–1279. https://doi.org/10.1136/annrheumdis-2013-203255
Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385(9976):1460–1471. https://doi.org/10.1016/S0140-6736(14)60720-0
Yamamoto M, Takahashi H, Suzuki C, Tabeya T, Ohara M, Naishiro Y, Yamamoto H, Imai K, Shinomura Y (2010) Analysis of serum IgG subclasses in Churg-Strauss syndrome--the meaning of elevated serum levels of IgG4. Intern Med 49(14):1365–1370. https://doi.org/10.2169/internalmedicine.49.3532
Yoo J, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW (2019) No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study. Clin Rheumatol 38(4):1147–1154. https://doi.org/10.1007/s10067-018-4402-x
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW Jr, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100. https://doi.org/10.1002/art.1780330806
Kawashima H, Utsugi A, Shibamiya A, Iida K, Mimura N, Ohashi H, Hase R, Kawakami M, Yanagisawa T, Hiraguri M (2019) Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. Immunol Res 67(1):99–107. https://doi.org/10.1007/s12026-019-9070-7
Erden A, Bolek EC, Yardimci KG, Kilic L, Bilgen SA, Karadag O (2019) Do ANCA-associated vasculitides and IgG4-related disease really overlap or not? Int J Rheum Dis 22(10):1926–1932. https://doi.org/10.1111/1756-185X.13693
Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16(10):1036–1043. https://doi.org/10.1016/j.autrev.2017.07.020
Cortazar FB, Stone JH (2015) IgG4-related disease and the kidney. Nat Rev Nephrol 11(10):599–609. https://doi.org/10.1038/nrneph.2015.95
Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, Rech J, Sinico RA, Bonatti F, Battistelli L, Distler JH, Schett G, Zwerina J (2012) IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis 71(3):390–393. https://doi.org/10.1136/ard.2011.155382
Nirula A, Glaser SM, Kalled SL, Taylor FR (2011) What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 23(1):119–124. https://doi.org/10.1097/BOR.0b013e3283412fd4
Mizuma A, Kouchi M, Kijima C, Yutani S, Uesugi T, Nagata E, Takizawa S (2018) A case of recurrent Mikulicz's disease with mononeuritis multiplex. Cent Eur J Immunol 43(4):490–494. https://doi.org/10.5114/ceji.2018.81349
Ohyama K, Koike H, Iijima M, Hashimoto R, Tomita M, Kawagashira Y, Satou A, Nakamura S, Sobue G (2013) IgG4-related neuropathy: a case report. JAMA Neurol 70(4):502–505. https://doi.org/10.1001/jamaneurol.2013.658
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group (2020) The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 79(1):77–87. https://doi.org/10.1136/annrheumdis-2019-216561
Yoo BW, Song JJ, Park YB, Lee SW (2020) 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al. Ann Rheum Dis:annrheumdis-2020-217086. https://doi.org/10.1136/annrheumdis-2020-217086
Sato S, Morimoto J, Oguchi Y, Umeda T, Kawamata T, Rikimaru M, Koizumi T, Togawa R, Suzuki Y, Sato Y, Uematsu M, Minemura H, Nikaido T, Fukuhara A, Saito J, Kanazawa K, Tanino Y, Munakata M, Shibata Y (2018) A case of eosinophilic granulomatosis with polyangiitis complicated with a IgG4 related disease like symptoms. Case Reports Immunol 2018:3763084–3763084. https://doi.org/10.1155/2018/3763084
Acknowledgements
We would like to thank Dr. Minyoung Kevin Kim and Editage (www.editage.co.kr) for English language editing.
Funding
This research was supported by a grant from the Korea Health Technology R and D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (HI14C1324).
Author information
Authors and Affiliations
Contributions
Sang-Won Lee and Juyoung Yoo contributed to the study conception and design. Juyoung Yoo and Jason Jungsik Song contributed to acquisition of material and data. Juyoung Yoo, Yong-Beom Park and Sang-Won Lee contributed to the analysis and interpretation of data. The first draft of the manuscript was written by Byung-Woo Yoo, and all authors commented and revised on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Disclosures
None.
Ethical approval
This study was approved by the institutional Review Board (IRB) of Severance Hospital (4–2019-0695).
Informed consent
The patient’s written informed consent was waived by the approving IRB, as this was a retrospective study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yoo, J., Song, J.J., Park, YB. et al. Definite IgG4-related disease had no overlap with eosinophilic granulomatosis with polyangiitis in Korean patients: a pilot study in one centre. Clin Rheumatol 39, 3009–3015 (2020). https://doi.org/10.1007/s10067-020-05104-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05104-5